Short answer first, then the reasoning. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.
I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
The question I want answered is how people are thinking about the trade-off between reversibility and privacy, because you cannot have both.
I have searched first, so if this is covered somewhere point me at it and I will read it.
BenResearch_OR said:The useful move here is to separate what is established from what is widely repeated.
True, and it depends on a baseline nobody has stated. Without knowing where someone started, the same number can be an excellent result or a disappointing one.
Happy to go further on any of that.
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference Standardsjosh_phd_bmore said:I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
Second this. The detail I would add is minor and it is already implied above.
Adding the clinical framing, because it changes how the question reads. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.
I would rather be corrected than agreed with, if it comes to it.